325 related articles for article (PubMed ID: 27731393)
21. Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia.
Cha J; Wang Z; Ao L; Zou N; Dinarello CA; Banerjee A; Fullerton DA; Meng X
Ann Thorac Surg; 2008 May; 85(5):1678-85. PubMed ID: 18442564
[TBL] [Abstract][Full Text] [Related]
22. Hydroxysafflor yellow a inhibits lipopolysaccharide-induced inflammatory signal transduction in human alveolar epithelial A549 cells.
Song L; Zhu Y; Jin M; Zang B
Fitoterapia; 2013 Jan; 84():107-14. PubMed ID: 23160090
[TBL] [Abstract][Full Text] [Related]
23. The cardioprotective effect of salidroside against myocardial ischemia reperfusion injury in rats by inhibiting apoptosis and inflammation.
Zhu L; Wei T; Gao J; Chang X; He H; Luo F; Zhou R; Ma C; Liu Y; Yan T
Apoptosis; 2015 Nov; 20(11):1433-43. PubMed ID: 26385354
[TBL] [Abstract][Full Text] [Related]
24. Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice.
Zhang Y; Song L; Pan R; Gao J; Zang BX; Jin M
Biol Pharm Bull; 2017; 40(2):135-144. PubMed ID: 28154251
[TBL] [Abstract][Full Text] [Related]
25. Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.
Ye J; Wang R; Wang M; Fu J; Zhang Q; Sun G; Sun X
Oxid Med Cell Longev; 2021; 2021():6643615. PubMed ID: 34093960
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of hydroxysafflor yellow A alone or in combination with acetylglutamine on cerebral ischemia reperfusion injury in rat: A PET study using
Deng L; Wan H; Zhou H; Yu L; He Y
Eur J Pharmacol; 2018 Apr; 825():119-132. PubMed ID: 29438705
[TBL] [Abstract][Full Text] [Related]
27. RP105 protects against myocardial ischemia-reperfusion injury via suppressing TLR4 signaling pathways in rat model.
Li X; Yang J; Yang J; Dong W; Li S; Wu H; Li L
Exp Mol Pathol; 2016 Apr; 100(2):281-6. PubMed ID: 26742900
[TBL] [Abstract][Full Text] [Related]
28. Hydroxysafflor Yellow A Reprograms TLR9 Signalling Pathway in Ischaemic Cortex after Cerebral Ischaemia and Reperfusion.
Gong Z; Pan J; Li X; Wang H; He L; Peng Y
CNS Neurol Disord Drug Targets; 2018; 17(5):370-382. PubMed ID: 29732997
[TBL] [Abstract][Full Text] [Related]
29. Adeno-associated Virus 9-mediated Small RNA Interference of TLR4 Alleviates Myocardial Ischemia and Reperfusion Injury by Inhibition of the NF-κB and MAPK Signaling Pathways in Rats.
Xu T; Zhang K; Kan F; Li F; Yu B; Du W; Nie H
Curr Mol Med; 2019; 19(2):127-135. PubMed ID: 30854968
[TBL] [Abstract][Full Text] [Related]
30. Hydroxysafflor yellow A protects neuron against hypoxia injury and suppresses inflammatory responses following focal ischemia reperfusion in rats.
Ye SY; Gao WY
Arch Pharm Res; 2008 Aug; 31(8):1010-5. PubMed ID: 18787790
[TBL] [Abstract][Full Text] [Related]
31. Hydroxysafflor Yellow A Attenuates Lipopolysaccharide-Induced Neurotoxicity and Neuroinflammation in Primary Mesencephalic Cultures.
Wang T; Ding YX; He J; Ma CJ; Zhao Y; Wang ZH; Han B
Molecules; 2018 May; 23(5):. PubMed ID: 29783643
[TBL] [Abstract][Full Text] [Related]
32. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
Jin M; Sun CY; Zang BX
Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
[TBL] [Abstract][Full Text] [Related]
33. Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway.
Zhou D; Ding T; Ni B; Jing Y; Liu S
Int J Mol Med; 2019 Aug; 44(2):405-416. PubMed ID: 31173173
[TBL] [Abstract][Full Text] [Related]
34. Hydroxysafflor yellow A suppresses inflammatory responses of BV2 microglia after oxygen-glucose deprivation.
Li J; Zhang S; Lu M; Chen Z; Chen C; Han L; Zhang M; Xu Y
Neurosci Lett; 2013 Feb; 535():51-6. PubMed ID: 23333598
[TBL] [Abstract][Full Text] [Related]
35. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo.
He D; Guo Z; Pu JL; Zheng DF; Wei XF; Liu R; Tang CY; Wu ZJ
Int Immunopharmacol; 2016 Jun; 35():201-209. PubMed ID: 27064547
[TBL] [Abstract][Full Text] [Related]
37. Role of toll-like receptor 4 in melatonin-induced cardioprotection.
Nduhirabandi F; Lamont K; Albertyn Z; Opie LH; Lecour S
J Pineal Res; 2016 Jan; 60(1):39-47. PubMed ID: 26465095
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol, a polyphenol phytoalexin, protects cardiomyocytes against anoxia/reoxygenation injury via the TLR4/NF-κB signaling pathway.
Zhang C; Lin G; Wan W; Li X; Zeng B; Yang B; Huang C
Int J Mol Med; 2012 Apr; 29(4):557-63. PubMed ID: 22246136
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol attenuates inflammation in the rat heart subjected to ischemia-reperfusion: Role of the TLR4/NF-κB signaling pathway.
Li J; Xie C; Zhuang J; Li H; Yao Y; Shao C; Wang H
Mol Med Rep; 2015 Feb; 11(2):1120-6. PubMed ID: 25405531
[TBL] [Abstract][Full Text] [Related]
40. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS].
Wu W; Jin M; Tong J; Wang XF; Zang BX
Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
